These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19539214)

  • 1. Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.
    Stiff PJ; Bensinger W; Abidi MH; Gingrich R; Artz AS; Nademanee A; Hansen KS; Sobczak C; Cutler C; Bolwell B; Shore TB; Lazarus HM; Yeager AM; Lovelace W; Guo M; Dreiling L
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):827-34. PubMed ID: 19539214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience.
    Anderlini P; Donato M; Chan KW; Huh YO; Gee AP; Lauppe MJ; Champlin RE; Körbling M
    Transfusion; 1999 Jun; 39(6):555-60. PubMed ID: 10378833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
    Kroschinsky F; Hölig K; Poppe-Thiede K; Zimmer K; Ordemann R; Blechschmidt M; Oelschlaegel U; Bornhauser M; Rall G; Rutt C; Ehninger G
    Haematologica; 2005 Dec; 90(12):1665-71. PubMed ID: 16330441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.
    Grigg AP; Roberts AW; Raunow H; Houghton S; Layton JE; Boyd AW; McGrath KM; Maher D
    Blood; 1995 Dec; 86(12):4437-45. PubMed ID: 8541532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
    Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
    Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of G-CSF on peripheral blood progenitor cell mobilization and collection from healthy donors.
    Chaisiripoomkere W; Jootar S; Ungkanont A
    Asian Pac J Allergy Immunol; 2001 Sep; 19(3):183-90. PubMed ID: 11826913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients.
    Glaspy JA; Shpall EJ; LeMaistre CF; Briddell RA; Menchaca DM; Turner SA; Lill M; Chap L; Jones R; Wiers MD; Sheridan WP; McNiece IK
    Blood; 1997 Oct; 90(8):2939-51. PubMed ID: 9376574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.
    Sivgin S; Karakus E; Keklik M; Zararsiz G; Solmaz M; Kaynar L; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2016 Jun; 54(3):410-5. PubMed ID: 27052362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.
    Anderlini P; Przepiorka D; Seong C; Smith TL; Huh YO; Lauppe J; Champlin R; Körbling M
    Transfusion; 1997 May; 37(5):507-12. PubMed ID: 9149776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors.
    Anderlini P; Donato M; Lauppe MJ; Huh YO; Martin TG; Chan KW; Champlin RE; Körbling M
    Br J Haematol; 2000 Jun; 109(4):770-2. PubMed ID: 10929027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes.
    Sica S; Rutella S; Di Mario A; Salutari P; Rumi C; Ortu la Barbera E; Etuk B; Menichella G; D'Onofrio G; Leone G
    J Hematother; 1996 Aug; 5(4):391-7. PubMed ID: 8877714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection.
    da Silva MG; Pimentel P; Carvalhais A; Barbosa I; Machado A; Campilho F; Sousa SR; Miranda N; da Costa FL; Campos A; Vaz CP; Antas J; Passos-Coelho JL
    Bone Marrow Transplant; 2004 Oct; 34(8):683-91. PubMed ID: 15322567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization.
    Dincer AP; Gottschall J; Margolis DA
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):761-3. PubMed ID: 15543014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.
    Chin-Yee IH; Keeney M; Stewart AK; Belch A; Bence-Buckler I; Couban S; Howson-Jan K; Rubinger M; Stewart D; Sutherland R; Paragamian V; Bhatia M; Foley R
    Bone Marrow Transplant; 2002 Dec; 30(12):851-60. PubMed ID: 12476276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
    Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
    Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
    Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
    Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
    Liang ZY; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.